Complement Inhibitor Treatment: The Growing Market for PNH Therapy Solutions
Complement inhibitor treatment has revolutionized the management of paroxysmal nocturnal hemoglobinuria (PNH), offering a targeted approach to controlling the disease's debilitating symptoms. These therapies, which block the complement cascade, have significantly improved patient outcomes and quality of life. The market for complement inhibitor treatment is expanding, driven by a...
0 Comentários 0 Compartilhamentos 135 Visualizações 0 Anterior